Intratio
Quantitative Research
Skip to main content
AI Market Summary
Loading market intelligence...
AI 90-DAY FORECAST
BEARISH SIGNAL DETECTED · Alpha
██.█% Sign up free to reveal

Avai Bio, Inc. (AVAI) AI Forecast

Our AI ranks Avai Bio, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

✓ Free account • ✓ 30-day free trial

$AVAI Bearish Signal Full forecast available

Avai Bio, Inc. (AVAI) Stock Forecast Sept. 25, 2026


Avai Bio, Inc. (AVAI) AI Stock Price Forecast & Investment Analysis

Avai Bio, Inc. Stock Price Chart and Technical Analysis

Loading chart...

Avai Bio, Inc. (AVAI) - Comprehensive Stock Analysis & Investment Research

Deep dive into Avai Bio, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Analysis updated on Sept. 25, 2026 (UTC)

Avai Bio, Inc. Investment Summary

When evaluating whether Avai Bio, Inc. (AVAI) represents a compelling investment opportunity, investors must consider multiple factors including the company's financial health, market position, growth prospects, and what our AI-powered predictive models suggest about its near-term price trajectory.

Company Profile

Avai Bio, Inc. (AVAI) operates within the Technology sector, specifically in the Services-Computer Processing & Data Preparation industry. With a market capitalization of $20 million, the company is a small-cap stock that may offer higher growth potential but also carries higher volatility.

Financial Performance Analysis

Our comprehensive financial analysis covers Avai Bio, Inc.'s revenue, profitability metrics, balance sheet strength, and cash flow generation...

AI Price Predictions

Get AI-powered 7-day, 30-day and 90-day price forecasts for Avai Bio, Inc. along with confidence scores and detailed analysis...

Investment Considerations

Expert analysis of whether Avai Bio, Inc. is suitable for your investment objectives, risk tolerance, and time horizon...

Continue Reading Full Analysis

Get the complete investment breakdown for Avai Bio, Inc.

Sign Up Free
Corporate Identity

Avai Bio, Inc. (Stock Symbol: AVAI) is a prominent company operating within the Technology sector, with a specific focus on the Services-Computer Processing & Data Preparation industry. The company's shares are publicly traded on the OTC exchange.

Leadership & Workforce

Detailed information about Avai Bio, Inc.'s leadership team, workforce size, and organizational structure...

Market Classification

Market capitalization analysis and stock classification (mega-cap, large-cap, mid-cap, small-cap) for Avai Bio, Inc....

Sector & Industry Analysis

In-depth sector dynamics and industry context for Avai Bio, Inc....

Unlock Full Company Profile

Get complete details about Avai Bio, Inc.

Sign Up Free
Revenue & Growth Analysis
Profitability Metrics

Net profit margin, gross margin, and operating margin analysis for Avai Bio, Inc....

Market Valuation

P/E ratio, price-to-book, and valuation multiples for Avai Bio, Inc....

Return Metrics

Return on equity (ROE), return on assets (ROA), and capital efficiency for Avai Bio, Inc....

Unlock Financial Analysis

Get complete financial metrics for Avai Bio, Inc.

Sign Up Free
AI ANALYSIS AVAILABLE

Unlock Avai Bio, Inc.'s AI Price Forecast

Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

4537 Stocks in the out-of-sample test
73.7% Rebalance periods with a positive net return
Daily Updates
Start 30-Day Free Trial →

✓ 30-day free trial • ✓ Cancel anytime

Strategic Market Position

Avai Bio, Inc. strategically competes in the highly dynamic Services-Computer Processing & Data Preparation marketplace. As a small-cap company, it represents an emerging market participant with potentially significant growth opportunities. Small-caps often offer greater growth potential as they capture market share and scale their operations, though this comes with higher risk and volatility. Success at this stage can lead to substantial returns for early investors who identify winning business models.

Industry Competitive Landscape

Avai Bio, Inc. operates within the fast-evolving technology sector where competitive dynamics are shaped by innovation cycles, platform economics, and network effects. Technology companies must continuously invest in R&D to maintain relevance, while also defending against disruption from startups and adjacent market entrants. Success in this sector often requires achieving critical scale or establishing defensible intellectual property positions.

Operational Efficiency
Financial Strength & Leverage

The current ratio stands at 0.04. This reflects potential liquidity concerns, with current liabilities exceeding current assets. While some businesses operate successfully with negative working capital, the specific circumstances warrant closer examination.

Avai Bio, Inc. (AVAI) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Avai Bio, Inc. stock analysis.

Deep dive into Avai Bio, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Avai Bio, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Avai Bio, Inc.:

Market Cap $20M
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Avai Bio, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Avai Bio, Inc.:

ROA -266.8%
ROIC 63.5%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Avai Bio, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Avai Bio, Inc.: A current ratio of 0.04 suggests potential liquidity concerns.

Current Ratio 0.04x
Interest Coverage 0.8x
Working Capital -$4M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Avai Bio, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Avai Bio, Inc.:

Operating Cash Flow -$1M
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Avai Bio, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Avai Bio, Inc.:

Understanding Financial Statement Data

What these metrics mean: Key figures from Avai Bio, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Avai Bio, Inc.:

Income Statement
Operating Income -$2M
Net Income -$2M
Balance Sheet Highlights (USD millions)
Total Current Assets $150K
Cash & Short-term Investments $80K
Total Liabilities $4M
Short-term Debt $2M
Dividend & Shareholder Information
Shares Outstanding 154M

Latest Avai Bio, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Avai Bio, Inc. (AVAI) stock price and investment outlook.

More news available

Sign up free to read all 10 news articles and stay updated on market developments.

Sign Up Free to Read More

Where AVAI sits on the market map

Explore the map →

Avai Bio, Inc. Industry Peers - Services-Computer Processing & Data Preparation

Companies classified under the same SEC industry code as Avai Bio, Inc. (Services-Computer Processing & Data Preparation): 60 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Company Ticker Symbol 90-Day AI Forecast (Alpha) Market Cap (USD M) P/E Ratio P/B Ratio
AVAI ██% $20M x x
ADP ██% $104.75B 23.7x 17.4x
JOYY ██% $83.85B x 269.0x
WDAY ██% $46.03B 36.8x 18.5x
RDDT ██% $29.38B 33.7x 8.9x
VRSK ██% $22.10B 24.8x x
TOST ██% $17.40B 35.8x 8.5x
APLD ██% $7.65B x 4.5x
HNGE ██% $7.42B x 21.6x
RNG ██% $6.67B x 104.9x
QBTS ██% $6.45B x 6.0x
PEGA ██% $5.63B 17.4x 10.0x
FA ██% $3.37B x 2.6x
LIF ██% $3.36B 22.8x 5.5x
INFQ ██% $3.22B x 5.6x
CARG ██% $2.79B 19.4x 10.6x
FIVN ██% $2.67B x 3.4x
INOD ██% $2.47B 53.2x 15.5x
RAMP ██% $2.28B 14.6x 1.7x
SHAZ ██% $2.02B x 1.8x
TRVG ██% $1.95B x 9.2x
DXC ██% $1.70B 13.7x 0.6x
EVTC ██% $1.68B 17.3x 2.6x
HAWK ██% $1.57B x 2.0x
GLOB ██% $1.53B x x
BRUN ██% $1.33B x x
GDRX ██% $1.14B x 1.8x
CLVT ██% $1.14B x 0.3x
UPWK ██% $1.01B 9.9x 1.7x
LZ ██% $968M 57.4x 7.6x
PLTK ██% $828M x x
TASK ██% $732M 6.8x 2.4x
YEXT ██% $640M x 18.0x
OOMA ██% $605M x 6.2x
CARS ██% $584M x 1.3x
IBEX ██% $574M 12.4x 3.4x
SOPH ██% $566M x x
NRDS ██% $524M x 1.6x
FCCN ██% $473M x 8.2x
GRVY ██% $469M x x
GLOO ██% $437M x x
EGHT ██% $332M 69.8x 2.3x
AIAI ██% $235M x 0.2x
FIRY ██% $212M x 2.5x
SSTK ██% $153M x 0.4x
TRAK ██% $150M x 3.0x
VERI ██% $134M x 3.5x
TCX ██% $114M x x
DTCX ██% $80M x 1.1x
BHIC ██% $77M x 42.2x
CAST ██% $49M x x
PHUN ██% $40M x 0.5x
DDI ██% $32M x x
SJ ██% $30M x x
BIRD ██% $28M x x
AUUD ██% $7M x 0.7x
SDCH ██% $7M x 5.2x
VS ██% $7M x 0.6x
DTST ██% $7M x 0.7x
ONEI ██% $7M x x
Reveal all forecasts See exact % predictions for all competitors
Sign up free

Frequently Asked Questions - Avai Bio, Inc. Stock Forecast

How accurate are Avai Bio, Inc. stock predictions?

A per-ticker accuracy statistic for AVAI is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

What factors influence Avai Bio, Inc. stock price forecasts?

Our analysis considers Avai Bio, Inc.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Avai Bio, Inc. a good investment in 2026?

Based on our AI analysis, Avai Bio, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Avai Bio, Inc. forecasts updated?

Avai Bio, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Sept. 25, 2026.

Want a simpler view of Avai Bio, Inc.?

View simplified analysis on AI Stock Finder →

My Portfolio

Investment Dashboard

Loading your portfolio...